The Chemed Corp. Forecasted to Earn Q1 2017 Earnings of $1.77 Per Share (CHE)

The Chemed Corp. Forecasted to Earn Q1 2017 Earnings of $1.77 Per Share (CHE)

Chemed Corp. (NYSE:CHE) – Research analysts at Oppenheimer Holdings reduced their Q1 2017 earnings estimates for shares of Chemed Corp. in a research note issued to investors on Thursday. Oppenheimer Holdings analyst M. Wiederhorn now expects that the brokerage will earn $1.77 per share for the quarter, down from their previous forecast of $1.79. Oppenheimer Holdings has a “Outperform” rating and a $155.00 price target on the stock. Oppenheimer Holdings also issued estimates for Chemed Corp.’s Q2 2017 earnings at $1.88 EPS, Q3 2017 earnings at $1.92 EPS and Q4 2017 earnings at $2.29 EPS.

Chemed Corp. (NYSE:CHE) last issued its quarterly earnings data on Wednesday, October 26th. The company reported $1.73 earnings per share for the quarter, missing analysts’ consensus estimates of $1.82 by $0.09. The firm had revenue of $392.61 million for the quarter, compared to the consensus estimate of $270.44 million. Chemed Corp. had a return on equity of 23.95% and a net margin of 6.77%. The company’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.78 EPS.

CHE has been the topic of several other reports. Zacks Investment Research cut Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Friday, July 29th. Royal Bank Of Canada lifted their price objective on Chemed Corp. from $136.00 to $162.00 and gave the company a “sector perform” rating in a research report on Wednesday, July 27th. RBC Capital Markets reaffirmed a “sector perform” rating and set a $162.00 price objective (up from $136.00) on shares of Chemed Corp. in a research report on Wednesday, July 27th. Finally, JMP Securities reaffirmed a “hold” rating on shares of Chemed Corp. in a research report on Sunday, September 4th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $161.50.

Shares of Chemed Corp. (NYSE:CHE) opened at 138.22 on Monday. Chemed Corp. has a 52-week low of $124.77 and a 52-week high of $160.12. The firm has a 50 day moving average price of $139.95 and a 200-day moving average price of $136.54. The company has a market cap of $2.23 billion, a price-to-earnings ratio of 22.06 and a beta of 1.17.

Several institutional investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Chemed Corp. by 147.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 947 shares of the company’s stock valued at $129,000 after buying an additional 565 shares during the last quarter. BlackRock Inc. raised its position in Chemed Corp. by 90.4% in the first quarter. BlackRock Inc. now owns 1,152 shares of the company’s stock valued at $156,000 after buying an additional 547 shares during the last quarter. Public Employees Retirement System of Ohio raised its position in Chemed Corp. by 3.5% in the second quarter. Public Employees Retirement System of Ohio now owns 1,319 shares of the company’s stock valued at $180,000 after buying an additional 45 shares during the last quarter. Fifth Third Bancorp raised its position in Chemed Corp. by 6.8% in the second quarter. Fifth Third Bancorp now owns 1,374 shares of the company’s stock valued at $187,000 after buying an additional 88 shares during the last quarter. Finally, 1st Global Advisors Inc. acquired a new position in Chemed Corp. during the third quarter valued at about $201,000. Hedge funds and other institutional investors own 98.95% of the company’s stock.

In other news, insider Kevin J. Mcnamara sold 18,000 shares of Chemed Corp. stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $144.87, for a total transaction of $2,607,660.00. Following the completion of the transaction, the insider now directly owns 163,266 shares in the company, valued at $23,652,345.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Arthur V. Tucker, Jr. sold 4,500 shares of Chemed Corp. stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $144.28, for a total transaction of $649,260.00. Following the transaction, the vice president now owns 7,734 shares of the company’s stock, valued at $1,115,861.52. The disclosure for this sale can be found here. Insiders own 5.32% of the company’s stock.

Chemed Corp. Company Profile

Related posts

Leave a Comment